427 filings
NT 10-Q
HEPA
Hepion Pharmaceuticals Inc
15 May 24
Notice of late quarterly filing
4:46pm
10-K
2023 FY
HEPA
Hepion Pharmaceuticals Inc
Annual report
16 Apr 24
4:53pm
NT 10-K
HEPA
Hepion Pharmaceuticals Inc
1 Apr 24
Notice of late annual filing
4:30pm
8-K
HEPA
Hepion Pharmaceuticals Inc
6 Mar 24
Departure of Directors or Certain Officers
4:15pm
8-K
HEPA
Hepion Pharmaceuticals Inc
20 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
8ufzf9zh12ow9
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
8-K
mgyjend2twlvffj5zg
7 Feb 24
Departure of Directors or Certain Officers
4:15pm
8-K
o77usa55i5k0h1
3 Jan 24
Changes in Registrant's Certifying Accountant
4:30pm
8-K
i5pd3fr
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
NT 10-Q
nb7db x6ff
14 Nov 23
Notice of late quarterly filing
4:46pm
EFFECT
bhfa3grz
9 Nov 23
Notice of effectiveness
12:15am
CORRESP
cym05agu203mcn
6 Nov 23
Correspondence with SEC
12:00am
UPLOAD
ico7d
3 Nov 23
Letter from SEC
12:00am
D
rl2i r0nz8vlop0cvb9
3 Oct 23
$5.00 mm in equity / options, sold $5.00 mm, 1 investor
5:22pm
8-K
bstclwt
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
2s170up5au
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
n65nc
6 Sep 23
Departure of Directors or Certain Officers
4:40pm